Cladribine
Key facts
Active substance |
Cladribine
|
Therapeutic area |
Neurology
|
Decision number |
P/101/2009
|
PIP number |
Cladribine
|
Pharmaceutical form(s) |
Tablet
|
Condition(s) / indication(s) |
Multiple Sclerosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
KGaA
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|